Cargando…

Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19

Detalles Bibliográficos
Autores principales: Zhang, Da‐Wei, Li, Fang, Wei, Yuan‐Yuan, Hu, Lei, Chen, Su‐Hong, Yang, Ming‐Ming, Zhang, Wen‐Ting, Fei, Guang‐He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242253/
https://www.ncbi.nlm.nih.gov/pubmed/37278129
http://dx.doi.org/10.1002/ctm2.1294
_version_ 1785054177118912512
author Zhang, Da‐Wei
Li, Fang
Wei, Yuan‐Yuan
Hu, Lei
Chen, Su‐Hong
Yang, Ming‐Ming
Zhang, Wen‐Ting
Fei, Guang‐He
author_facet Zhang, Da‐Wei
Li, Fang
Wei, Yuan‐Yuan
Hu, Lei
Chen, Su‐Hong
Yang, Ming‐Ming
Zhang, Wen‐Ting
Fei, Guang‐He
author_sort Zhang, Da‐Wei
collection PubMed
description
format Online
Article
Text
id pubmed-10242253
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102422532023-06-07 Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 Zhang, Da‐Wei Li, Fang Wei, Yuan‐Yuan Hu, Lei Chen, Su‐Hong Yang, Ming‐Ming Zhang, Wen‐Ting Fei, Guang‐He Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-06-05 /pmc/articles/PMC10242253/ /pubmed/37278129 http://dx.doi.org/10.1002/ctm2.1294 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Zhang, Da‐Wei
Li, Fang
Wei, Yuan‐Yuan
Hu, Lei
Chen, Su‐Hong
Yang, Ming‐Ming
Zhang, Wen‐Ting
Fei, Guang‐He
Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title_full Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title_fullStr Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title_full_unstemmed Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title_short Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
title_sort development and validation of a novel cd4(+) t cell‐related gene signature to detect severe covid‐19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242253/
https://www.ncbi.nlm.nih.gov/pubmed/37278129
http://dx.doi.org/10.1002/ctm2.1294
work_keys_str_mv AT zhangdawei developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT lifang developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT weiyuanyuan developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT hulei developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT chensuhong developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT yangmingming developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT zhangwenting developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19
AT feiguanghe developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19